Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Hong Kong stocks slammed as investors dump Chinese financials amid trade war anxieties

2018-07-03 scmp
The Shanghai Composite Index drops further after sliding to a 28-month low; the yuan falls to the weakest since last August
CRBJY CICHY 506186 1109 CRBJF GLXYENT CICHF CCB 1088 0939

6
China, Hong Kong stocks wobble on trade war fears

2018-06-21 thehindubusinessline
China and Hong Kong shares reversed earlier gains to slide on Thursday, as concerns over a trade spat between China and the United States weighed on sentiment.
1336 CGHLY JINDALSAW 0914 500378 CGHOF CEO 1088 0384

0
Hong Kong stocks end lower after Trump says he’s ‘not pleased’ with progress on US-China trade talks

2018-05-23 scmp
Hong Kong and mainland stocks fell on Wednesday after US President Donald Trump said he was “not pleased” with the progress of US-China trade talks, which had fuelled market optimism in recent days.
1898 HUNGF HNP 0902 1088

15
Hong Kong stocks eke out gains as investors remain optimistic over US-China trade talks

2018-05-18 scmp
Hong Kong markets closed slightly higher on Friday amid optimism of a breakthrough in US-China trade negotiations even as talks entered a second day in Washington.
0700 MS 1088

119
What Does Reform In China Really Mean For Equity Investors?

2018-05-15 seekingalpha
Portfolio Managers Charlie Awdry and May Ling Wee discuss the progress of political, business, financial and social reforms in China under President Xi's leadership, and its implications for markets and investors.
SHI BABA JHG BIDU CEO 1088

8
Should You Invest in the IQ Global Resources ETF (GRES)?

2018-05-02 zacks
Looking for broad exposure to the Materials - Broad segment of the U.S. equity market? You should consider the IQ Global Resources ETF (GRES - Free Report) , a passively managed exchange traded fund launched on 10/27/2009.
TSNU DQ TXN GRES FENY TSN 1088

0
Hong Kong stocks rise as financials climb

2018-04-30 thehindubusinessline
Hong Kong’s main Hang Seng index rose to a more than one-week high by lunch break on Monday, as strength in overseas markets provided support, with banks and financial stocks leading the charge, while China's H-shares index climbed to an over two-week high.
3968 0914 1088

35
50 Top Basic Materials Dividend Yields For March

2018-03-27 seekingalpha - 2
Coal, wood, glass, & chemicals topped March's basic materials sector for gains, calculated by broker 1-year targets on 3/23/18.
ARLP CCR TGLS AHGP EXXAY SXCP CINR WLK EXXAF MTGRF WLKP VEDL HCLP 1088 NRP MGX EVA VEDL MTGRY

0
Shenhua Profit Rises to 5-Year High as China Curbs Boost Coal - Bloomberg

2018-03-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
1898 YACAF YZC K3GD 1171 YZCHF YAL 1088

34
Five Things You Need to Know to Start Your Day - Bloomberg

2018-03-22 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
3968 FB 1088

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...